Close Menu

23andMe has gotten the go-ahead from the US Food and Drug Administration to sell its genetic health risk report on three BRCA1 and BRCA2 mutations that increase a person's chances of developing breast cancer, as GenomeWeb reports. These variants are most common among people of Ashkenazi Jewish descent, though they are found to a lesser degree among individuals of other ethnic backgrounds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.